Advertisement

Index by Author

May 2000; 49 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aizawa, T

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  2. Aminian, S

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  3. Anello, M

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

  4. Anggård, E

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  5. Arner, P

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688
    • Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes May 2000 49:797-802; doi:10.2337/diabetes.49.5.797

  6. Assmann, G

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  7. Atkinson, M A

    • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes May 2000 49:708-711; doi:10.2337/diabetes.49.5.708

  8. Azen, S P

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

B

  1. Bandy, D

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  2. Baron, A D

    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes May 2000 49:684-687; doi:10.2337/diabetes.49.5.684
    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  3. Belluardo, N

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  4. Benjamin, N

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  5. Berkowitz, K

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  6. Bolinder, J

    • Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes May 2000 49:797-802; doi:10.2337/diabetes.49.5.797

  7. Bonner-Weir, S

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  8. Bowes, S B

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  9. Brooks, H L

    • Localization of glucokinase gene expression in the rat brain. Diabetes May 2000 49:693-700; doi:10.2337/diabetes.49.5.693

  10. Brunner, F

    • Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes May 2000 49:803-809; doi:10.2337/diabetes.49.5.803

  11. Bryer-Ash, M

    • Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes May 2000 49:810-819; doi:10.2337/diabetes.49.5.810

  12. Buchanan, T A

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

C

  1. Carroll, P V

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  2. Challis, B G

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  3. Chandramouli, V

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  4. Charollais, A

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  5. Chen, K

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  6. Cheung, A T

    • Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes May 2000 49:810-819; doi:10.2337/diabetes.49.5.810

  7. Christ, E R

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  8. Cline, G W

    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

  9. Condorelli, D F

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  10. Corkey, B

    • Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes May 2000 49:718-726; doi:10.2337/diabetes.49.5.718

  11. Cronin, J

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  12. Croos, P

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

D

  1. Dansky, H M

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  2. Drucker, D J

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  3. Dufour, S

    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

  4. Dunn-Meynell, A A

    • Localization of glucokinase gene expression in the rat brain. Diabetes May 2000 49:693-700; doi:10.2337/diabetes.49.5.693
    • Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes May 2000 49:820-826; doi:10.2337/diabetes.49.5.820

E

  1. Egan, J M

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  2. Eiberg, H

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  3. Ellis, T M

    • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes May 2000 49:708-711; doi:10.2337/diabetes.49.5.708

F

  1. Fajans, S S

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  2. Fantus, I G

    • Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes May 2000 49:863-871; doi:10.2337/diabetes.49.5.863

  3. Farfari, S

    • Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes May 2000 49:718-726; doi:10.2337/diabetes.49.5.718

  4. Farooqi, I S

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  5. Fleisher, M

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  6. Forte, P

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  7. Franke, T F

    • Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes May 2000 49:847-856; doi:10.2337/diabetes.49.5.847

  8. Fukui, Y

    • A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes May 2000 49:759-767; doi:10.2337/diabetes.49.5.759

G

  1. Gauntt, C J

    • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes May 2000 49:708-711; doi:10.2337/diabetes.49.5.708

  2. Gautier, J F

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  3. Goico, J

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  4. Goldberg, H J

    • Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes May 2000 49:863-871; doi:10.2337/diabetes.49.5.863

  5. Goto, T

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

  6. Gowrie, I

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

H

  1. Habener, J F

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  2. Haefliger, J A

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  3. Hagström-Toft, E

    • Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes May 2000 49:797-802; doi:10.2337/diabetes.49.5.797

  4. Häkkinen, A M

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

  5. Halavaara, J

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

  6. Halsall, D J

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  7. Hansen, L

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  8. Hansen, T

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  9. Harris, R A

    • Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes May 2000 49:775-781; doi:10.2337/diabetes.49.5.775

  10. Hashizume, K

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  11. Heiman, M

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  12. Hofer, A

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  13. Holness, M J

    • Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes May 2000 49:775-781; doi:10.2337/diabetes.49.5.775

  14. Hook, G

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  15. Hovorka, R

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  16. Hussain, M A

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

I

  1. Inzucchi, S

    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

J

  1. Jackson, N

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  2. Jensen, J N

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  3. Johnson, A

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  4. Johnston, A

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

K

  1. Kahn, B B

    • Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes May 2000 49:847-856; doi:10.2337/diabetes.49.5.847

  2. Kaneko, T

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  3. Kelley, D E

    • Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes May 2000 49:677-683; doi:10.2337/diabetes.49.5.677

  4. Keogh, J M

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  5. Kerckhoffs, D A

    • Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes May 2000 49:797-802; doi:10.2337/diabetes.49.5.797

  6. Kieffer, T J

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  7. Kim, Y B

    • Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes May 2000 49:847-856; doi:10.2337/diabetes.49.5.847

  8. Kjos, S L

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  9. Kolls, J K

    • Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes May 2000 49:810-819; doi:10.2337/diabetes.49.5.810

  10. Komatsu, M

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  11. Kraus, A

    • Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes May 2000 49:775-781; doi:10.2337/diabetes.49.5.775

  12. Kristiansen, O P

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  13. Krssak, M

    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

L

  1. Landau, B R

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  2. Lazaridis, E N

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  3. Le Gurun, S

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  4. Leslie, R D

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  5. Levin, B E

    • Localization of glucokinase gene expression in the rat brain. Diabetes May 2000 49:693-700; doi:10.2337/diabetes.49.5.693
    • Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes May 2000 49:820-826; doi:10.2337/diabetes.49.5.820

  6. Löfgren, P

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  7. Luan, J

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  8. Lynch, R M

    • Localization of glucokinase gene expression in the rat brain. Diabetes May 2000 49:693-700; doi:10.2337/diabetes.49.5.693

M

  1. Mandarino, L J

    • Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes May 2000 49:677-683; doi:10.2337/diabetes.49.5.677

  2. Marroquin, A

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  3. Masui, S

    • A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes May 2000 49:759-767; doi:10.2337/diabetes.49.5.759

  4. Meda, P

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  5. Moberg, E

    • Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes May 2000 49:797-802; doi:10.2337/diabetes.49.5.797

  6. Morrow, J D

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  7. Motojima, K

    • A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes May 2000 49:759-767; doi:10.2337/diabetes.49.5.759

N

  1. Näslund, E

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  2. Nerup, J

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  3. Nowotny, P

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

O

  1. O'Byrne, S

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  2. O'Rahilly, S

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  3. Ochoa, C

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  4. Osada, S

    • A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes May 2000 49:759-767; doi:10.2337/diabetes.49.5.759

  5. Ottendorfer, E W

    • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes May 2000 49:708-711; doi:10.2337/diabetes.49.5.708

P

  1. Patanè, G

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

  2. Pedersen, O

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  3. Peroni, O D

    • Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes May 2000 49:847-856; doi:10.2337/diabetes.49.5.847

  4. Petersen, H V

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  5. Petersen, K F

    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

  6. Peters, R K

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

  7. Piro, S

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

  8. Pociot, F

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  9. Pratley, R E

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  10. Prentki, M

    • Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes May 2000 49:718-726; doi:10.2337/diabetes.49.5.718

  11. Purrello, F

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

R

  1. Rabuazzo, A M

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

  2. Ravussin, E

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  3. Ree, D

    • Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes May 2000 49:810-819; doi:10.2337/diabetes.49.5.810

  4. Reiman, E M

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  5. Reynisdottir, S

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  6. Roberts, L J, 2nd

    • Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes May 2000 49:857-862; doi:10.2337/diabetes.49.5.857

  7. Roden, M

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  8. Rössner, S

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  9. Russell, J C

    • Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes May 2000 49:803-809; doi:10.2337/diabetes.49.5.803

  10. Russell-Jones, D L

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  11. Rydén, M

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  12. Ryysy, L

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

S

  1. Salbe, A D

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  2. Sato, Y

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  3. Scholey, J

    • Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes May 2000 49:863-871; doi:10.2337/diabetes.49.5.863

  4. Schulz, V

    • Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes May 2000 49:718-726; doi:10.2337/diabetes.49.5.718

  5. Schumann, W C

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  6. Serre-Beinier, V

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

  7. Serreze, D V

    • Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes May 2000 49:708-711; doi:10.2337/diabetes.49.5.708

  8. Serup, P

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

  9. Shankar, R R

    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes May 2000 49:684-687; doi:10.2337/diabetes.49.5.684

  10. Sharp, G W

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  11. Shen, H Q

    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes May 2000 49:684-687; doi:10.2337/diabetes.49.5.684

  12. Shih, D Q

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  13. Shulman, G I

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701
    • Mechanism of troglitazone action in type 2 diabetes. Diabetes May 2000 49:827-831; doi:10.2337/diabetes.49.5.827

  14. Sönksen, P H

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  15. Steinberg, H O

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  16. Stingl, H

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  17. Stoffel, M

    • Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes May 2000 49:832-837; doi:10.2337/diabetes.49.5.832

  18. Stoffers, D A

    • Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes May 2000 49:741-748; doi:10.2337/diabetes.49.5.741

  19. Straub, S G

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  20. Sugden, M C

    • Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes May 2000 49:775-781; doi:10.2337/diabetes.49.5.775

T

  1. Tarshoby, M

    • Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes May 2000 49:768-774; doi:10.2337/diabetes.49.5.768

  2. Tataranni, P A

    • Differential brain responses to satiation in obese and lean men. Diabetes May 2000 49:838-846; doi:10.2337/diabetes.49.5.838

  3. Tkacs, N C

    • Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes May 2000 49:820-826; doi:10.2337/diabetes.49.5.820

  4. Tompkins, L S

    • Localization of glucokinase gene expression in the rat brain. Diabetes May 2000 49:693-700; doi:10.2337/diabetes.49.5.693

  5. Trovato-Salinaro, A

    • Cx36 preferentially connects beta-cells within pancreatic islets. Diabetes May 2000 49:727-734; doi:10.2337/diabetes.49.5.727

U

  1. Umesono, K

    • A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes May 2000 49:759-767; doi:10.2337/diabetes.49.5.759

  2. Umpleby, A M

    • IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes May 2000 49:789-796; doi:10.2337/diabetes.49.5.789

  3. Urioste, S

    • NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes May 2000 49:876-878; doi:10.2337/diabetes.49.5.876

V

  1. van Harmelen, V

    • Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes May 2000 49:688-692; doi:10.2337/diabetes.49.5.688

  2. Vehkavaara, S

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

  3. Vigneri, R

    • Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes May 2000 49:735-740; doi:10.2337/diabetes.49.5.735

W

  1. Waldhäusl, W

    • Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes May 2000 49:701-707; doi:10.2337/diabetes.49.5.701

  2. Wang, J

    • Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes May 2000 49:810-819; doi:10.2337/diabetes.49.5.810

  3. Wareham, N J

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  4. Wascher, T C

    • Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes May 2000 49:803-809; doi:10.2337/diabetes.49.5.803

  5. Westerbacka, J

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

  6. Wölkart, G

    • Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes May 2000 49:803-809; doi:10.2337/diabetes.49.5.803

  7. Wu, Y

    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes May 2000 49:684-687; doi:10.2337/diabetes.49.5.684

X

  1. Xiang, A H

    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes May 2000 49:782-788; doi:10.2337/diabetes.49.5.782

Y

  1. Yajima, H

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  2. Yamada, S

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  3. Yamauchi, K

    • Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes May 2000 49:712-717; doi:10.2337/diabetes.49.5.712

  4. Yeo, G S

    • The CART gene and human obesity: mutational analysis and population genetics. Diabetes May 2000 49:872-875; doi:10.2337/diabetes.49.5.872

  5. Yki-Järvinen, H

    • Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes May 2000 49:749-758; doi:10.2337/diabetes.49.5.749

Z

  1. Zhu, J S

    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes May 2000 49:684-687; doi:10.2337/diabetes.49.5.684

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement